Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Par Drugs IPO.
April 16, 2024 1:47:00 PM
(Reuters) -Ibotta, the digital marketing company backed by Walmart, said on Tuesday it was looking to raise about $551 million in an upsized initial public offering in the United States.
Published by : U.S. News & World ReportApril 1, 2024 7:48:00 PM
The electronic bidding of Techno Drugs Limited to determine the cut-off price of its shares is scheduled to begin on 21 April and will continue until 24 April. General investors will get the company's ...
Published by : tbsnewsMarch 19, 2024 10:10:00 PM
Based in San Diego, the company has two drugs in early-to-mid stage clinical development. The company just completed a Phase 1 study for its candidate PIPE-791 for MS and IPF. Its second candidate ...
Published by : Seeking AlphaMarch 29, 2024 3:30:00 AM
An IPO could happen as early as late July as the company looks to cash in on investor excitement about the next generation of weight-loss drugs and a revival in the biotech IPO market. A total of ...
Published by : The Financial TimesFebruary 19, 2024 5:14:00 AM
Zenith Drugs IPO: Zenith Drugs initial public offering (IPO) will open for subscription today (February 19). Through the issue, Zenith Drugs aims to raise ?40.6 crore and list the shares on the ...
Published by : Hindustan Times on MSNMarch 28, 2024 4:45:00 PM
The company has developed a diagnostic to identify patients amenable to treatment with an ecDNA-directed drug. In the IPO filing, the company said it is working with an in vitro diagnostic company ...
Published by : MedCity NewsApril 4, 2024 3:30:00 AM
By this time last year, only four drug startups had gone public, raising $375 million. In 2022, nine companies had pulled in $744 million. The IPO activity has been accompanied by a step-up in ...
Published by : Yahoo FinanceMarch 5, 2024 3:17:00 PM
IPO Stock Faces Competition Apogee is facing some competition in eczema treatment, however. It's going up against Eli Lilly's drug, lebrikizumab. Both drugs target IL-13, a critical cytokine in ...
Published by : MSNMarch 11, 2024 5:24:00 PM
Together, the stock sales would be worth about $748 million, with Reddit raising about $519 million for the company through the IPO. Based on its total number of shares outstanding, the ...
Published by : CBS NewsMarch 18, 2024 3:30:00 AM
Contineum Therapeutics has become the latest biotech to file for an initial public offering (IPO) in the US, hoping to raise $150 million for its early clinical-stage candidate for progressive ...
Published by : pharmaphorumApril 10, 2024 11:07:00 AM
By this time last year, only four drug startups had gone public, raising $375 million. In 2022, nine companies had pulled in $744 million. The IPO activity has been accompanied by a step-up in funding ...
Published by : Yahoo FinanzasThe allotment status of Par Drugs and Chemicals Limited IPO is now available online. The public issue of Par Drugs IPO was open on May 3, 2019 and closed for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME.
The IPO Shares of Par Drugs and Chemicals Limited IPO are proposed to list on Thursday, May 16, 2019 at NSE SME. The public issue of Par Drugs IPO was opened on May 3, 2019 and closed for subscription on May 8, 2019. Par Drugs IPO Listing Date and Information:
Par Drugs and Chemicals Limited is entering in the capital market with an IPO of 1,700,000 Equity Shares of Rs 10 aggregating up to Rs 8.53 Crore. The price for the issue has been set at Rs 51 Per Equity Share.
Incorporated in 1999, Gujarat based Par Drugs and Chemicals Limited is engaged in the business of manufacturing and developing active pharma ingredients (API) for the Indian and international markets. APIs are used as the main ingredient in making tablets, capsules, and other finished dosages. The company also produces various antacid molecules which are in great demand in the market.
The issue opens on May 3, 2019 and closes for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME.
The issue of Par Drugs and Chemicals Limited opens on May 3, 2019 and closes for subscription on May 8, 2019. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 51 Per Equity Share.
The Par Drugs IPO is proposed to open on May 3, 2019. The IPO application ends on May 8, 2019.
Retail investors can apply in the retail or non-institutional investor category from May 3, 2019 to May 8, 2019. The Par Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Par Drugs IPO will open for subscription on May 3, 2019. The public issue will close on May 8, 2019.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
